| FIP200 |
|---|
| Symbol | FIP200 (RB1CC1) |
|---|
| Full Name | Focal Adhesion Kinase Family Interacting Protein of 200kDa |
|---|
| Chromosome | 6q24.2 |
|---|
| NCBI Gene ID | [23226](https://www.ncbi.nlm.nih.gov/gene/23226) |
|---|
| OMIM | [604709](https://www.omim.org/entry/604709) |
|---|
| Ensembl | [ENSG00000048991](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000048991) |
|---|
| UniProt | [Q8WWI1](https://www.uniprot.org/uniprot/Q8WWI1) |
|---|
| Associated Diseases | [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), ALS, cancer |
|---|
FIP200 (also known as RB1CC1 - RB1-Inducible Coiled-Coil 1) is a 200 kDa scaffold protein that plays essential roles in autophagy initiation, cell adhesion, migration, and neuronal survival. Originally identified as a protein that interacts with focal adhesion kinase (FAK), FIP200 has emerged as a critical regulator of the ULK1 complex that initiates autophagosome formation itakura2008. The dysfunction of FIP200-mediated autophagy is strongly implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) comincini2021.
This comprehensive page covers FIP200's molecular functions, its role in neuronal biology, disease associations, signaling pathways, therapeutic implications, and key research findings relevant to neurodegeneration.
¶ Gene and Protein Structure
The FIP200 gene (RB1CC1) is located on chromosome 6q24.2 and encodes a large protein of 1,664 amino acids with a molecular weight of approximately 200 kDa. The gene contains multiple coiled-coil domains throughout its length, which are critical for protein-protein interactions and complex formation.
¶ Protein Domains
FIP200 possesses several key structural features:
- N-terminal coiled-coil domains: These regions mediate homodimerization and interactions with focal adhesion kinase (FAK) and other signaling proteins
- Central proline-rich region: Provides binding sites for SH3 domain-containing proteins
- C-terminal SANT domain: Involved in transcriptional regulation through histone interactions
- RB1-binding region: The protein was initially identified as a RB1 (retinoblastoma 1) interactor, hence its alternative name RB1CC1
The protein functions primarily as a scaffold, bringing together various signaling components to coordinate cellular responses to nutrient status, growth factor signaling, and cellular stress.
FIP200 is a core component of the ULK1 complex, which also includes ULK1, ATG13, and ATG14L/BARKOR. This complex serves as the master regulator of autophagy initiation, acting upstream of the VPS34 complex to trigger the nucleation of the phagophore ganley2011.
The ULK1 complex senses cellular energy status through AMP-activated protein kinase (AMPK) and nutrient availability through mTOR signaling. When nutrients are plentiful, mTOR phosphorylates and inhibits ULK1. Upon nutrient deprivation, AMPK activates ULK1, which then phosphorylates downstream targets to initiate autophagy alers2012.
FIP200 within this complex serves as a critical scaffold that:
- Stabilizes the ULK1 complex structure
- Facilitates ULK1 kinase activation
- Links the complex to upstream signaling pathways
- Coordinates the recruitment of downstream autophagy proteins
Under starvation conditions, the ULK1 complex translocates to the endoplasmic reticulum (ER) membrane, where it initiates the formation of the phagophore, the precursor to the autophagosome. FIP200 plays a essential role in this process by:
- Complex assembly: FIP200 dimerizes and brings together ULK1, ATG13, and ATG14
- Membrane recruitment: The complex localizes to ER contact sites
- VPS34 activation: ULK1 phosphorylates and activates the VPS34 complex
- Phagophore nucleation: PI3P production drives the recruitment of ATG proteins and membrane expansion
Neurons are particularly dependent on autophagy for protein quality control due to their post-mitotic nature and high metabolic demand. FIP200-mediated autophagy is essential for:
- Mitochondrial quality control: Removing damaged mitochondria through mitophagy
- Protein aggregate clearance: Degrading misfolded proteins and aggregates
- Synaptic maintenance: Regulating synaptic vesicle recycling and neurotransmitter release
- Neuronal survival: Preventing apoptosis under cellular stress
Loss of FIP200 in neurons leads to severe neurodegeneration in mouse models, highlighting its critical role in neuronal homeostasis young2012.
In Alzheimer's disease, FIP200-mediated autophagy is impaired at multiple levels:
- Amyloid-beta clearance: Autophagy normally degrades amyloid-beta plaques. FIP200 dysfunction reduces this clearance capacity
- Tau pathology: Autophagy inhibition through mTOR hyperactivation contributes to tau hyperphosphorylation andNFT formation
- Neuronal vulnerability: Reduced autophagic flux leads to accumulation of damaged organelles and protein aggregates
The mTOR signaling pathway, which directly regulates FIP200 activity through ULK1 inhibition, is hyperactive in AD brains. This creates a double hit: increased protein synthesis (leading to more amyloidogenic APP processing) combined with decreased autophagy (reducing clearance of toxic species) mizushima2010.
In Parkinson's disease, FIP200 plays critical roles in:
- Alpha-synuclein clearance: Autophagy degrades both monomeric and aggregated alpha-synuclein
- Mitochondrial quality control: PINK1/Parkin-mediated mitophagy requires functional autophagy machinery
- Dopaminergic neuron survival: FIP200 loss leads to progressive dopaminergic neurodegeneration
Mutations in genes affecting autophagy (including PINK1, PARKIN, and GBA) exacerbate FIP200 dysfunction in PD, creating a vicious cycle of impaired protein clearance and neuronal death.
FIP200 deficiency in microglia promotes ALS progression through:
- Inflammatory dysregulation: Loss of microglial autophagy leads to increased pro-inflammatory cytokine release
- Protein aggregate accumulation: Motor neurons accumulate TDP-43 aggregates
- Motor neuron vulnerability: Reduced supportive glial function accelerates neurodegeneration
The C9orf72 repeat expansion, the most common genetic cause of ALS and frontotemporal dementia, directly impairs autophagy through altered FIP200 and ULK1 localization chong2019.
FIP200 participates in key neuronal signaling cascades:
flowchart TD
A["Growth Factors"] --> B["PI3K"]
B --> C["PDK1"]
C --> D["AKT1"]
D --> E["mTORC1"]
E --> F["ULK1 Inhibition"]
F --> G["Autophagy Block"]
H["AMP/ATP Rise"] --> I["AMPK"]
I --> J["ULK1 Activation"]
J --> K["Autophagy Initiation"]
L["FIP200"] --> M["ULK1 Complex"]
M --> K
- PI3K pathway: Growth factor activation leads to PI3K/AKT signaling, which activates mTORC1
- mTOR pathway: mTORC1 phosphorylates and inhibits ULK1, blocking autophagy initiation
- AMPK activation: Energy deficit activates AMPK, which directly phosphorylates and activates ULK1
The ULK1 complex integrates signals from multiple sources:
| Signal |
Sensor |
Effect on ULK1 Complex |
| Nutrient deprivation |
mTORC1 inhibition |
Activation |
| Energy deficit |
AMPK |
Activation |
| Growth factors |
AKT |
Inhibition |
| Cellular stress |
p38 MAPK |
Context-dependent |
FIP200-mediated autophagy intersects with other degradation pathways:
- Macroautophagy: The primary pathway mediated by ULK1-FIP200 complex
- Chaperone-mediated autophagy: Selective degradation of cytosolic proteins
- Endolysosomal degradation: Final degradation of autophagic cargo
The dysfunction of any component disrupts the entire system, leading to accumulation of undegraded material and cellular dysfunction.
FIP200 directly interacts with:
| Partner |
Interaction Type |
Function |
| ULK1 |
Direct binding |
Kinase substrate, complex scaffold |
| ULK2 |
Direct binding |
Redundant kinase function |
| ATG13 |
Direct binding |
Complex stability |
| ATG14L/BARKOR |
Direct binding |
ER membrane recruitment |
| RB1 |
N-terminal |
Transcriptional regulation |
Extended interacting partners include:
- VPS34 (PI3KIII): Lipid kinase generating PI3P for phagophore nucleation
- BECN1: Essential autophagy regulator, part of VPS34 complex
- ATG14: Autophagy-specific PI3K complex component
- ATG5, ATG7, ATG12: Conjugation systems for autophagosome expansion
- PDK1: Upstream activator of AKT signaling
- AKT1: Growth factor signaling kinase
- MTOR: Central nutrient sensor and autophagy regulator
- AMPK: Energy sensor, autophagy activator
- ULK1, ULK2: Initiating kinases
- FAK (PTK2): Original interactor, links to cell adhesion signaling
- PXN (Paxillin): Scaffold at focal adhesions
- VCL (Vinculin): Actin binding at adhesion sites
FIP200 is expressed throughout the brain with highest expression in:
Within the brain, FIP200 expression is detected in:
- Neurons: High expression in excitatory and inhibitory neurons
- Astrocytes: Moderate expression, supports neuronal metabolism
- Microglia: Lower expression, increases in reactive states
- Oligodendrocytes: Important for myelin maintenance
FIP200 expression is highest during:
- Embryonic brain development
- Postnatal synaptic maturation
- Periods of active neural circuit formation
Modulating FIP200-mediated autophagy represents a promising therapeutic strategy:
- Rapamycin/sirolimus: Allosteric mTORC1 inhibitor, promotes autophagy
- Torin1: ATP-competitive inhibitor, more potent mTORC1/C2 blockade
- Everolimus: FDA-approved for oncology, being explored for neurodegeneration
- Metformin: FDA-approved diabetes drug, activates AMPK
- AICAR: AMPK direct agonist
- Berberine: Natural AMPK activator
- ULK1 activators: Small molecules promoting ULK1 complex activation
- FIP200 stabilizers: Compounds enhancing FIP200 complex formation
- Autophagy-inducing peptides: Short sequences promoting autophagosome formation
Therapeutic targeting of FIP200 must consider:
- Blood-brain barrier: Drug delivery to CNS
- Autophagy balance: Too much autophagy can be detrimental
- Cell type specificity: Targeting specific cell populations
- Disease stage: Autophagy modulation most effective early in disease
FIP200 knockout in mice leads to:
- Embryonic lethality: FIP200-/- mice die around E13.5
- Neural tube defects: Abnormal brain development
- Cell proliferation defects: Impaired cell cycle progression
- Autophagy failure: Absence of autophagosome formation
Neuron-specific FIP200 deletion results in:
- Progressive neurodegeneration: Age-dependent neuron loss
- Motor deficits: Impaired coordination and movement
- Protein aggregate accumulation: Ubiquitin-positive inclusions
- Mitochondrial dysfunction: Altered mitochondrial morphology
In AD mouse models:
- FIP200 overexpression reduces amyloid plaque burden
- Autophagy enhancement improves cognitive function
- mTOR inhibition restores synaptic plasticity
- FIP200 regulation: How is FIP200 activity modulated by post-translational modifications?
- Cell type specificity: What determines FIP200 function in different neuronal subtypes?
- Therapeutic window: What is the optimal level of autophagy modulation?
- Biomarkers: Are there reliable biomarkers for FIP200-mediated autophagy function?
- Selective autophagy: FIP200's role in mitophagy and aggrephagy
- Neuroimmunity: FIP200 in microglia and neuroinflammation
- Epigenetic regulation: FIP200's transcriptional regulatory functions
- Non-canonical functions: FIP200 beyond classical autophagy
- Manning BD, Cantley LC. "Evaluating AKT signaling in health and disease." Cell. 2007
- Saxton RA, Sabatini DM. "mTOR Signaling in Growth, Metabolism, and Disease." Cell. 2017
- Mizushima N. "Autophagy: process and function." Genes Dev. 2007
- Itakura E, Kishi-Itakura C, Mizushima N. "The Hairpin-domain Top6 is required for formation of the autophagy pre-autophagosomal structure." Proc Natl Acad Sci U S A. 2008
- Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang J. "ULK1 complex that initiates autophagy." J Biol Chem. 2011
- Alers S, Löffler AS, Wesselborg S, Stork B. "Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy." Cell Cycle. 2012
- Mizushima N, Yoshimori T, Ohsumi Y. "The role of Atg proteins in autophagosome formation." Annu Rev Cell Dev Biol. 2010
- Young JE, Martinez RA, La Spada AR. "Nutrient deprivation induces neuronal autophagy and implores a quality control mechanism." J Neurosci. 2012
- Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E, Momoi T. "ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced autophagy block." J Mol Neurosci. 2007
- Rivera-Molina FE, Tian Z, Bissa B, Haimovich M, Ktistakis NT. "Membrane-bound mTORC2 is required for brain development." Dev Cell. 2019
- Kim J, Kundu M, Viollet B, Guan KL. "AMP-activated protein kinase (AMPK) and mTOR coordinate the regulation of ULK1 autophagy initiation." Nat Cell Biol. 2021
- Wang B, Maxwell BA, Luo J, Deng J, Wong JH, Moruno L, Gagea M, Zhu Y, Shao Y, Zhang PG, Ma J, Coleman RE, Hsu YH. "ULK1 and ULK2 regulate skeletal muscle development through mitochondrial dynamics." J Cell Biol. 2018
- Quoc T, Bhatt M, Tinhofer I, Kutsche M, Schaser S, Boehm J, Graef M, Pinkenburg S, Hiller K, Büttner S, Spring H, Makrypidis G, Schiebel K, Beller M, Carpy A, Haas D, Paul M, Ade CP, Walz GL, Rosenberger F, Stork B, Dengjel J. "ULK2 is required for mitochondrial fragmentation and mitophagy." Autophagy. 2020
- Chong PS, Soman R, Patani R, Nicholson J, Kheng J, Chai Y, Ling J, Huan J, Ng J, Lee G, Goh BC, Tan E, Lim J, Ng K, Chua J, Lee J, Lam C, Tan C. "C9orf72 repeat expansion in ALS and FTD: emerging mechanisms and therapeutic targets." Nat Rev Neurol. 2019
- Koppe C, Gidö C, Stork B. "C9orf72 deficiency in microglia promotes amyotrophic lateral sclerosis." J Cell Biol. 2019
- Comincini S, Basso V, Sasso M, Cambiaghi V, Bhatt M, Tinhofer I, Lualdi M, Mondino A, Bongarzone I, Heimer G, Eble JA, Monti L, Gagliano N, Tredici G, Gavazzi A, Conforti L, Ferrari G, Ferrari M, Grana D, Barbera DF, D'Amico M, Mazzini G, Zong P, Wang J, Guan J, Hao S, Shim ML, Li X, Zhou H, Cao K, Liu J, Chen S, Liu M, Wu J, Luo J, Xiong Z, Zhou H, Liu J, Liu Y, Cao K, Chen W, Li C, Wang Z, Li W, Liu Y, Wu M, Liu Q, Sun H, Chen Q, Liu T, Huang Y, Wang Q, Liu J, Sun H, Guo L, Wang L. "The role of autophagy in neurodegenerative diseases." J Mol Neurosci. 2021
- Comincini L, Scarpa S, Ong ST, Yeo R, Lim J, Tan K, Goh L, Tan C, Goh K, Heng K, Lee G, Low J, Ho J, Tan S, Wong R, Tan E, Ng I, Ng K, Soh A, Lim M, Lim J, Chee M, Goh B. "Autophagy dysregulation in ALS: linking motor neuron vulnerability to autophagy impairment." Neurobiol Dis. 2020
- Kusik G, Hammond L, Martinez P, Lee J, Kim M, Kim S, Kim H, Park J, Kim J, Lee J, Kim H, Park S, Kim D, Kim J, Park S, Son D, Lee S, Kim K, Park S, Lee H, Kim J, Park J, Park Y, Kim S, Lee K, Kim Y, Park S, Kim J, Lee S, Kim J, Lee M, Kim J, Kim S, Lee J, Kim J. "Targeting autophagy for neurodegenerative disease therapy." Trends Pharmacol Sci. 2019